About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, May 12th, 2015

The QualityStocks
Daily Stock List


Stellar Biotechnologies, Inc. (SBOTF)

Contrarian Press, Pennybuster, Tip.us, Stock Analyzer, Top Stock Picks, and Investor Relations reported earlier on Stellar Biotechnologies, Inc. (SBOTF), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Founded in 1999, Stellar Biotechnologies, Inc. is the leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH). This is an important immune-stimulating protein used in comprehensive therapeutic and diagnostic markets. Stellar Biotechnologies’ dedication is to meeting the rising demand for commercial-scale supplies of GMP grade KLH, ensuring environmentally sound KLH production, and developing KLH-based active immunotherapies. Stellar Biotechnologies is headquartered in Port Hueneme, California.

KLH is an active pharmaceutical ingredient (API) in many new immunotherapies (targeting cancer, immune disorders, Alzheimer's and inflammatory diseases). KLH is also a finished product for measuring immune status. The Company developed the proprietary ability to sustainably produce GMP grade KLH. Its primary business is the manufacture and supply of KLH protein. It has expanded its pipeline with the acquisition of its own active immunotherapy program for the treatment of Clostridium difficile infection.

Stellar Biotechnologies has important intellectual property (IP) related to the processing, purification, and engineering of stabilized formulations of KLH protein. Stellar has greater than fifteen years of KLH production expertise and the world’s only demonstrated aquaculture systems for sustainable, controlled production of fully-traceable, GMP grade KLH.

KLH manufacturing is limited by the fact that this essential molecule can only be produced from a scarce marine source. The Company believes it is the only business that has the technology to manage the controlled production of this resource.

Stellar Biotechnologies and Araclon Biotech SL announced in November 2014 that the companies executed a definitive exclusive supply agreement to meet Araclon's Phase (II and III) clinical trial requirements for Keyhole Limpet Hemocyanin (KLH) used in Araclon's active immunotherapies against Alzheimer's disease.

The purpose of the agreement is to ensure a stable supply to Araclon of Stellar KLH™ for the ongoing clinical development of Araclon's Alzheimer's drugs. This includes the development of manufacturing processes, production capacity, as well as regulatory support. With this agreement, Araclon will manage and fund all product development and regulatory submissions for its products. Stellar Biotechnologies will supply GMP-grade Stellar KLH™ protein. Stellar will also provide technical and regulatory support to Araclon.

Yesterday, Stellar Biotechnologies announced its financial results for the second fiscal quarter and six months ended March 31, 2015. The Company produced revenue of $187,627 and $400,288 for the second quarter and six months ended March 31, 2015, respectively, versus $114,371 and $173,196 for the same periods in 2014.

The net loss for the second quarter ended March 31, 2015 was $426,164, or ($0.01) per basic share, versus a net loss of $1.4 million, or ($0.02) per basic share, for the quarter ending March 31, 2014. The net loss for the six months ended March 31, 2015 was $1.8 million, or ($0.02) per basic share, versus a net loss of $7.0 million, or ($0.09) per basic share, for the six months ended March 31, 2014.

Stellar Biotechnologies, Inc. (SBOTF), closed Tuesday's trading session at $0.78, up 2.90%, on 78,620 volume with 35 trades. The average volume for the last 60 days is 89,924 and the stock's 52-week low/high is $0.60/$2.36.

Dais Analytic Corp. (DLYT)

SmallCapVoice, StockRich, StockEgg, MadPennyStocks, BullRally, PennyInvest, HotOTC, PennyStockVille, CoolPennyStocks, Stockpalooza, and Money Morning reported previously on Dais Analytic Corp. (DLYT), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

Dais Analytic Corp. is a nanotechnology materials and process company concentrating on commercializing its technology in the global energy and water markets. It provides industry-changing, nanotechnology-based applications for heating & cooling, water treatment, and energy storage. Dais is commercializing its unique Aqualyte™ family of nano-structured materials and processes centering on disruptive air, energy, and water applications. Dais Analytic is based in Odessa, Florida.

The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™, a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product); and NanoAir™, which is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle.

Uses also include NanoClear™, which is an early beta-stage method for treating contaminated water (sea, waste, industrial) to provide 1,000 times cleaner potable water. The NanoClear™ process has consistently shown Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, attaining nearly 'parts per billion' clean product water with little or no fouling of the vital membrane component.

Uses also include NanoCAP™. Dais Analytic indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive non-chemical energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, and 'smart grid' configurations.

Dais Analytic announced in 2014 that it entered into a definitive agreement with SoEX (Hong Kong) Industry & Investment Co. to create a People’s Republic of China (PRC) company, owned by both parties, to build and sell Dais's ConsERV™ High Efficiency Energy Recovery Ventilator (ERV) into the greater China market and select use of Dais’ Aqualyte™ nanomaterial to clean up contaminated water. SoEX Hong Kong has an established manufacturing and distribution network.

In October 2014, Dais Analytic announced that SoEX (Beijing) Environmental Protection Technology Co., Ltd. a joint venture owned by Dais and SoEX (Hong Kong) Industry & Investment Co., Ltd., began production and distribution of the Company's ConsERV Energy Recovery Ventilator (ERV) product in China. SoEX (Beijing) is marketing the ConsERV product through its existing (and expanding) distribution network and design institutes, to large property owners and government entities looking to meet new air quality regulations in China.

Today, Dais Analytic announced it was chosen to receive additional funding of $1.2 million from the U.S Department of Energy (DOE) to further commercialize its Heating, Ventilation, and Air-Conditioning (HVAC) membrane technology for its NanoAir™ product. The award is part of a total investment of almost $8 million announced at the end of April by the Energy Department to advance R&D of next-generation heating, ventilating, and air conditioning (HVAC) technologies.

Dais Analytic Corp. (DLYT), closed Tuesday's trading session at $0.2001, down 4.71%, on 19,420 volume with 11 trades. The average volume for the last 60 days is 38,752 and the stock's 52-week low/high is $0.171/$0.40.

Agritek Holdings, Inc. (AGTK)

SmallCapVoice reported recently on Agritek Holdings, Inc. (AGTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Agritek Holdings, Inc. provides innovative, turnkey solutions for medicinal and canna-businesses within regulated jurisdictions across America.  It is the first fully reporting Company and pioneer within the medicinal marijuana space. Agritek does not directly grow, harvest, or distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it have any intention of so doing in the future.

Agritek provides unique patient and agricultural solutions. It is working to be the leader in Compassionate Care Technology and indoor/outdoor agricultural solutions for the recreational cannabis industry. It was the first public entity to offer electronically processed transactions within the medicinal marijuana sector.

Agritek distributes vertical business products and services to regulated cannabis businesses. This includes consulting and management services related to the purchase and lease of building and land operations within regulated jurisdictions; the Mont Blunt Brand of Vaporizers and e-Cig line; and Hemp based beverages. It also offers equipment leasing and credit facilities for large scale grow and retail operations via its established banking network.

Agritek Holdings has two wholly owned subsidiaries, “Agritek Venture Holdings, Inc.,” which holds all land acquisitions and leases, and “The American Hemp Trading, Inc.,” for hemp based beverages and products. Through Agritek Venture Holdings, it provides real estate services. This includes the acquisition, zoning, and infrastructure build of greenhouse operations and leasing of agricultural land developments zoned specifically for canna-businesses within licensed jurisdictions.

Agritek Holdings has executed and completed the asset acquisition of the entire line of products, technology, and customers of Dry Vapes Holdings, Inc. Dry Vapes’ plan is to roll out the complete product line to greater than 5,000 brick and mortar smoke shops nationally. Dry Vapes will continue to be manufactured under the "Mont Blunt™" brand name.

Agritek Holdings has executed an operational and licensing agreement with Green Leaf Farms Holdings, Inc., an 80 percent owned subsidiary of Player's Network (PNTV). The five year agreement provides for Agritek Holdings to be the exclusive consultant regarding the build out on behalf of Green Leaf for the 22,000 sq. ft. facility now under contract for purchase by an investment partner of Green Leaf for $2.8 million. Green Leaf currently has two provisional or "MME" licenses in North Las Vegas, Nevada for medicinal cannabis cultivation and production.

Agritek Holdings will provide consulting services and specialists related to grow and production, operational build out, equipment lease financing, and an infrastructure funding commitment of up to $1,000,000.

In April, Agritek Holdings announced the appointment of Dr. Stephen Holt as the newest member of its Advisory Board. Dr. Holt will use his extensive clinical and industry experience to assist Agritek in effectively developing IP within the nutraceutical sector, while simultaneously establishing new CBD based product lines. Dr. Holt is a nationally recognized licensed physician and author.

Agritek Holdings, Inc. (AGTK), closed Tuesday's trading session at $0.0161, up 1.26%, on 699,519 volume with 38 trades. The average volume for the last 60 days is 702,621 and the stock's 52-week low/high is $0.0152/$0.36.

Implant Sciences Corp. (IMSC)

INO.com Market Report reported recently on Implant Sciences Corp. (IMSC), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Implant Sciences Corp. is a high technology supplier of systems and sensors for homeland security and defense markets. It is a foremost manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications. The Company has developed proprietary technologies used in its commercial explosives and drugs trace detection systems, which ship to an increasing number of locations domestically and internationally.

Implant Sciences, in January 2013, became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. The Company develops and manufactures explosive trace detection sensors and systems that can detect minute amounts of a wide assortment of military, commercial, and homemade explosives.

Implant Sciences’ patented technologies provide unique screening capabilities to extend and improve counter-terrorist and homeland security efforts. All of its products have recognition as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. Its QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation.

The QS-H150 uses Ion Mobility Spectrometry (IMS) technology. It is constructed with no radioactive materials and features a low-maintenance, self-calibrating, and self-clearing design. The QS-H150 provides very high levels of operational availability. It has been proven to perform well in a broad array of temperatures and challenging environments.

Implant Sciences’ QS-B220 received TSA qualification for air cargo screening. The QS-B220 features a radioactive material-free design, push-button maintenance and diagnostics, and also a patented inCal™ internal automatic calibration system. Additionally, QS-B220 received STAC certification, a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act), and the GSN 2013 Homeland Security Award for "Best Explosives Detection Solution."

Implant Sciences’ ETDs have received approvals and certifications from many international regulatory agencies. These include the TSA in the United States, ECAC in Europe, STAC in France, the German Ministry of the Interior, and the Ministry of Public Safety in China. Implant Sciences announced this past January that its QS-B220 explosives and drugs trace detector received regulatory approval in Russia for transportation. Furthermore, the QS-B220 and QS-H150 also received the Customs Union Declaration of Conformity certification. These approvals allow Implant Sciences to sell the units to customers in Russia, Belarus, and Kazakhstan for the next five years. This is subject to U.S. export approval.

Yesterday, Implant Sciences announced that it was granted three new patents by the U.S. Patent and Trademark Office (USPTO). The patents, captioned "Non-Radioactive Ion Source Using High Energy Electrons", "Chemical Analysis Using Hyphenated Low and High Field Ion Mobility", and "Selective Ionization Using High-Frequency Filtering of Reactive Ions," expand the Company’s intellectual property (IP) protection and are expected to lead to even more effective Company products.

Implant Sciences Corp. (IMSC), closed Tuesday's trading session at $0.77, up 2.67%, on 85,994 volume with 37 trades. The average volume for the last 60 days is 152,263 and the stock's 52-week low/high is $0.66/$1.82.

Kips Bay Medical, Inc. (KIPS)

Equity Observer, Value Penny Stocks, Ascending Stocks, HotStockProfits, StockLockandLoad, StockBomb.com, ResearchOTC, StockRockandRoll, and PennyStockLocks.com reported earlier on Kips Bay Medical, Inc. (KIPS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed Kips Bay Medical, Inc. is a medical device company. Its focus is on manufacturing and commercializing its external saphenous vein support technology, the eSVS® Mesh, for use in coronary artery bypass grafting (CABG surgery). Kips Bay Medical is headquartered in Minneapolis, Minnesota.

Kips Bay Medical was established in 2007 by Mr. Manuel A. Villafaña, Chairman and Chief Executive Officer (CEO) of the Company. Mr. Villafaña has over 50 years of experience in the medical device industry. Kips Bay Medical originally acquired the eSVS Mesh® technology from Medtronic, Inc. in 2007.

The Company’s product is built on the proprietary eMesh technology platform. The intention of it is to provide improved outcomes for patients suffering with coronary artery disease who require CABG surgery. The design of its eSVS Mesh is to address the limitations of saphenous vein grafts (SVGs) used in CABG surgery. The eSVS Mesh® is fitted like a sleeve on the outside of saphenous vein grafts to strengthen SVGs used in CABG surgery.

The intention of the innovative design is also to ensure that blood flow is quicker and more laminar, through reducing the diameter mis-match between the SVG and target artery. The eSVS Mesh is manufactured from nitinol wire. This gives the eSVS Mesh substantial strength, while remaining highly flexible and kink-resistant.

Kips Bay Medical’s commitment is to performing clinical studies to demonstrate long-term outcome results for the eSVS Mesh technology. Presently, it is involved in a Food and Drug Administration (FDA)-mandated feasibility study and is sponsoring continuing post-market studies in Europe. The Company has received an updated CE Mark approving use of a new surgical implant technique for its eSVS® Mesh.

The eMESH I clinical feasibility trial is a multi-center, randomized study of external saphenous vein graft, or SVG, support using the Company's eSVS Mesh® in coronary artery bypass grafting surgery. The goal of the trial is to demonstrate to the FDA the initial safety and performance of the eSVS Mesh® for use as an external SVG support device during CABG surgery.

As of March 1, 2015, Kips Bay Medical reached its targeted goal of enrolling 45-50 patients, treated with its new surgical technique, in the eMESH I clinical feasibility trial. At present, 105 patients have been enrolled in the feasibility trial. This includes 49 patients enrolled with the new implant technique.

Recently, Kips Bay Medical announced that it entered into a securities purchase agreement with several investors, including Manny Villafana, its Chairman and CEO, and Kips Bay Investments, LLC, one of its principal stockholders. Such investors have agreed to purchase up to $3.25 million in shares of the Company's common stock in four equal tranches, subject to certain terms and conditions.

Kips Bay Medical has agreed to use the net proceeds from the private placement for working capital and general corporate purposes. This includes mainly funding the process of seeking regulatory approval to market the eSVS Mesh in the U.S. and overseas, including continuing human clinical trials.

Kips Bay Medical, Inc. (KIPS), closed Tuesday's trading session at $0.201, up 3.08%, on 45,275 volume with 6 trades. The average volume for the last 60 days is 47,948 and the stock's 52-week low/high is $0.121/$0.334.

Studio One Media, Inc. (SOMD)

SmarTrend Newsletters, SmallCapVoice, Jan Carroll, and FeedBlitz reported previously on Studio One Media, Inc. (SOMD), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Studio One Media, Inc. is a diversified media and technology company. Its wholly-owned subsidiaries include MyStudio, Inc. and AfterMaster HD Audio Labs, Inc. The Company has developed and commercialized several award winning, proprietary, leading-edge audio and video technologies for professional and consumer use. Studio One Media’s operational offices are in Scottsdale, Arizona. Its research, recording, and mastering studios are in Hollywood, California.

Studio One Media and its subsidiaries engage in the development and commercialization of proprietary (patents issued and pending), pioneering audio and video technologies for professional and consumer use. This includes MyStudio® HD Recording Studios, AfterMaster HD Audio™ and ProMaster HD audio™.

The Company has entered into licensing agreements with Sony/ATV Music Publishing, Universal Music Publishing Group, EMI Music Publishing, BMG Chrysalis, and strategic relationships with industry leaders. In 2014, Studio One Media entered into an agreement with ON Semiconductor Corp. to develop integrated circuits (ICs) using Studio One’s award-winning AfterMaster™ audio technology and ON Semiconductor’s DSP product development expertise.

AfterMaster™ is an innovative audio technology. It was originally developed for the mastering, re-mastering, and processing of audio through AfterMaster HD Audio Labs, a subsidiary of Studio One Media. The expectation is that the devices will provide an unprecedented level of audio clarity, depth, and loudness for consumer electronic devices.

The AfterMaster™ technology has been used by many leading musicians looking to create a fuller and richer sound quality than otherwise available in digital audio. AfterMaster Labs maintains five primary business units. These are professional music mastering, consumer electronics, online mastering, AfterMaster Recording and Mastering Studios and Audio Consulting services.

Studio One Media subsidiary, AfterMaster Audio Labs, announced in November 2014 that Justin Timberlake joined the Company as an owner. He will play an integral role as AfterMaster prepares its launch into the market, providing innovative technology and sound to the digital audio processing world. Mr. Timberlake will join a group of world-class audio engineers and music industry veterans. This includes AfterMaster Co-Founders Larry Ryckman, CEO, and Shelly Yakus, Chief Engineer.

ON Semiconductor announced in late April the release of BelaSigna 300® AM with AfterMaster HD Audio Labs, Inc., Studio One Media’s subsidiary. The new BelaSigna 300 AM digital signal processing (DSP) chip embedded with AfterMaster technology is a cutting-edge audio solution designed to considerably enhance the listening experience on any consumer device.

Studio One Media, Inc. (SOMD), closed Tuesday's trading session at $0.835, up 4.37%, on 263,884 volume with 77 trades. The average volume for the last 60 days is 45,641 and the stock's 52-week low/high is $0.20/$0.95.

Sangui BioTech International, Inc. (SGBI)

Real Pennies reported previously on Sangui BioTech International, Inc. (SGBI), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Sangui BioTech International, Inc. is a holding company listed on the OTC Markets’ OTCQB. Its mission is to provide financing and access to the capital markets for the enterprises of the Sangui group. Sangui BioTech has been a reporting company since 2000. The Company is headquartered in Witten, Germany. SanguiBioTech GmbH is a 90 percent subsidiary of Sangui BioTech International.

Sangui developed “Granulox”. It is the first dressing to considerably improve oxygen supply to wounds with poor blood supply and therefore definitively speeds up wound healing. In November 2014, Sangui BioTech International reported that preclinical trials demonstrate that Sangui hemoglobin preparation improves oxygen supply of vital organs.

A possible success in treating septic shock has been realized by the research team embracing SanguiBioTech GmbH, the Excellence Cluster Cardio Pulmonary System (ECCPS) and TransMIT Gesellschaft für Technologietransfer mbH. Preclinical trials at Giessen University reinforce that a hemoglobin based product developed by SanguiBioTech is apt to improve the oxygen supply of vital organs.

ECCPS is an organization set up jointly by the universities of Frankfurt and Giessen together with the Max Planck Institute for Heart and Lung Research in Bad Nauheim. TransMIT Gesellschaft für Technologietransfer mbH is the unit in charge of technology transfer at Justus-Liebig University in Giessen. TransMIT is involved in carrying out this project.

It is presently being thought that Sangui's hemoglobin-based artificial oxygen carriers may interrupt the self-perpetuating mechanism of septic shock. To date, septic shock has been highly resistant to treatment. Consequently, Sangui BioTech's hemoglobin-based artificial oxygen carriers may ultimately reduce the high mortality rates. Preclinical trials in Giessen demonstrate that an oxygen-carrying hemoglobin liquid in the abdomen did considerably improve the oxygen supply to the intestines.

Today, Sangui BioTech International announced that it secured a financial framework of $5 Million over three years. With this agreement, it acquires the right to sell shares to a fund of Southridge LLC, an institutional investor, located in Connecticut and New York in the amount of up to $5 million over a period of three years. The dilution of existing shareholders is limited to a maximum of 25 million shares of common stock. The agreement is subject to Sangui filing an S-1 registration statement with the Securities and Exchange Commission (SEC).

Sangui BioTech International, Inc. (SGBI), closed Tuesday's trading session at $0.08, up 17.65%, on 30,000 volume with 3 trades. The average volume for the last 60 days is 8,462 and the stock's 52-week low/high is $0.015/$0.16.


The QualityStocks
Company Corner


Pure Hospitality Solutions, Inc. (PNOW)

The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (PNOW). Today, Pure Hospitality Solutions, Inc. closed trading at $0.0038, up 11.76%, on 399,205 volume with 10 trades. The stock’s average daily volume over the past 60 days is 870,807, and its 52-week low/high is $0.0013/$0.5882.

Pure Hospitality Solutions, Inc. (PNOW) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.

The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Pure continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.

Operating a successful bi-lateral business model, Pure has four objectives:

1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;

2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;

3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,

4. Expand the portfolio of Pure-owned boutique hotels operating under the Hotel PURE brand.

The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.

Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer

Pure Hospitality Solutions, Inc. Company Blog

Pure Hospitality Solutions, Inc. News:

PURE Files 2014 Year End Disclosures with OTC Markets

National Tourism Center Of Costa Rica Gives Pure Opportunity

Pure's Oveedia Signs First Property

Galenfeha, Inc. (GLFH)

The QualityStocks Daily Newsletter would like to spotlight Galenfeha, Inc. (GLFH). Today, Galenfeha, Inc. closed trading at $0.34, up 6.25%, on 12,200 volume with 4 trades. The stock’s average daily volume over the past 60 days is 30,278, and its 52-week low/high is $0.1011/$4.00.

Galenfeha, Inc. (GLFH) is an engineering, product development, and manufacturing company that provides innovative solutions for oil and natural gas production, as well as stored energy products across a number of different industries. The company provides these products and services through its stored energy and oil & gas division.

Through its stored energy division, Galenfeha offers one of the most powerful, environmentally friendly battery systems in the market. The batteries have onboard computers, are inherently safe, internally temperature regulated, have optional GPS monitoring capabilities, offer significant weight reduction of up to 50%, and are engineered specifically for each type of application. Features include 100% “green” chemistry, RoHS compliancy, and active short circuit protection control.

Through its oil and gas division, the company offers chemical injection pumps that merge the perceived benefits of a hybrid, electric over pneumatic system. Galenfeha management believes the combination of the two parameter control systems represents a measurable shift in efficiency, reliability, cost management, and profitability to individual well locations as well as entire production fields. The combined technologies have demonstrated increased chemical injection accuracy, reducing chemical contamination in the production process while controlling cost and waste.

The company’s unwavering dedication is to continuously develop products that perform better than conventional solutions while also reducing environmental impact. Leveraging the management team’s wealth of resources and relationships, Galenfeha is well positioned for continued growth as the company aims to expand in both the stored energy and oil & gas industries. Disclaimer

Galenfeha, Inc. Company Blog

Galenfeha, Inc. News:

Galenfeha, Inc. Announces Engagement of QualityStocks Investor Relations Services

GALENFEHA, INC. Files SEC form 8-K, Change in Directors or Principal Officers

Galenfeha, Inc. Completes Field Testing, Begins Production and Shipping of New Battery System

Mobile Lads Corp. (MOBO)

The QualityStocks Daily Newsletter would like to spotlight Mobile Lads Corp. (MOBO). Today, Mobile Lads Corp. closed trading at $0.0799, up 0.63%, on 50,310 volume with 8 trades. The stock’s average daily volume over the past 60 days is 38,718, and its 52-week low/high is $0.05/$0.42.

Mobile Lads Corp. (MOBO) designs and delivers secure, wide-area wireless transaction software solutions for the consumer finance, web and health payment processing sectors. The company’s solutions provide streamlined, continuous access to time-sensitive information and data on multiple network standards. Mobile Lads’ products and services, offered through its Xtreme Mobility division, centers on three core technologies that simplify and secure wireless communications: xmVerify, xmBilling, and xmOne.

xmVerify is a real-time mobile transaction security service that prevents credit card fraud by giving users control over the authorization process when making purchases. Using one of the best cryptographic services, and in compliance with most all available platforms, xmVerify sends a transaction authorization request directly to the user’s mobile phone to ensure authenticity.

xmBilling is a mobile platform that provides customers with a convenient and secure way to review and authorize automatic billing transactions, easing the challenges of automated and volume-based billing. The system sends the user a text message with a URL leading to an online e-bill where they can review details of the bill and authorize the payment via credit card with the use of their PIN number.

The xmOne mobile platform provides an array of encrypted mobile services, including top-up, payment processing, emergency notification and marketing, ideal for students and higher education facilities. xmOne interfaces with a school’s existing campus card account system to enable students to perform a variety of banking transactions from their cell phones. The university or college benefits from increased usage of the flex-dollar ecosystem, reduces overhead from ADMs, and can be customized to each school’s individual brand.

Mobile Lads is guided by a management team with a unique blend of in-depth technical expertise in wireless channel communications and a solid background in business strategy and consumer analysis. The company’s vision is to grow as a leading-edge wireless solution provider by enabling innovative, wide-area communication solutions on a global scale. Disclaimer

Mobile Lads Corp. Company Blog

Mobile Lads Corp. News:

Mobile Lads Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International

Mobile Lads Begins Operating North American Shopping Network Simbadeals.com

Mobile Lads Purchases Majority of North American Shopping Network From Domark International

Loans4Less.com, Inc. (LFLS)

The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.10, even for the day, on 2,000 volume with 4 trades. The stock’s average daily volume over the past 60 days is 4,515, and its 52-week low/high is $0.015/$0.18.

Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.

Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.

The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.

Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulted on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer

Loans4Less.com, Inc. Company Blog

Loans4Less.com, Inc. News:

LOANS4LESS.COM Enters into an Acquisition Agreement with 321LEND

Loans4Less.com, Inc. Enters into an Investment Banking Agreement with WestPark Capital, Inc. and Seeks Bank Strategic Partner for National Mortgage Broker Origination and Brand Exposure Opportunity

Loans4Less.com Seeks a Merger, Joint Venture Partner and/or Investor for National Loan Origination and Brand Exposure Opportunity

Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.05, even for the day. The stock’s average daily volume over the past 60 days is 2,340 and its 52-week low/high is $0.05/$0.45.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview

Dominovas Energy Corp. Appoints International Business Professional to Board of Directors

Dominovas Energy and Delphi Sign MOU

Car Monkeys Group (CKMY)

The QualityStocks Daily Newsletter would like to spotlight Car Monkeys Group (CKMY). Today, Car Monkeys Group closed trading at $0.18, even for the day. The stock’s average daily volume over the past 60 days is 8,239, and its 52-week low/high is $0.05/$5.00.

Car Monkeys Group (CKMY), via CarMonkeys.com, is one of the largest and fastest growing online cars, vans and SUV parts distributors in the United States. Founded in 2010, the Wyckoff, New Jersey-based company formerly was known as Delaine Corporation and changed its name to Car Monkeys Group in February 2015.

With access to hundreds of thousands of parts, Car Monkeys sells used, high-quality, low-mileage automotive parts to consumers, retailers, truck and car fleet owners and auto repair facilities looking for a wide range of vehicle makes and models. Customers have access to a Part Finder section that helps them easily navigate and quickly locate the right parts they need.

Striving to provide customers a quick, hassle-free and convenient shopping experience, all parts ordered through CarMonkeys.com ship from one of the company’s numerous distributors and auto dismantling centers straight to the customer or their mechanic. Advantages such as a five-year unlimited mileage warranty, zero shipping costs, and a generous return policy further contribute to the increasing popularity of the Car Monkeys brand.

Automotive recycling plays a substantial role in the preservation of natural resources and reduction of demand for landfill space. According to the Automotive Recyclers Association, approximately 95% of vehicles retired from use are processed for recycling, saving an estimated 85 million barrels of oil that would have been used to manufacture new or replacement parts. As a rapidly growing and trusted automotive recycling company, Car Monkeys is positioned as a leading player in the broader $22 billion North American automotive recycling industry. Disclaimer

Car Monkeys Group Company Blog

Car Monkeys Group News:

Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services

Car Monkeys Group (CKMY) is “One to Watch”

Car Monkeys Group (CKMY) Continues Growth as one of the Country’s Largest Online Automobile Parts Distributors

MIT Holding (MITD)

The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.058, even for the day. The stock’s average daily volume over the past 60 days is 7,821, and its 52-week low/high is $0.032/$0.29.

MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.

In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.

MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer

MIT Holding Company Blog

MIT Holding News:

MIT Holding Achieves Positive Net Income From Operations in 2014

MIT Holding (MITD) Launches New Website with Investor Relations Suite

MIT Holding, Inc. Names Tommy J. Duncan as President


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251